Revenue
$9.83B
Fiscal year ended 2025-11-30Operating income
-$918.18M
Fiscal year ended 2025-11-30Free cash flow
$572.47M
Fiscal year ended 2025-11-30Concentrix Corp (CNXC) reported revenue of $9.83B and net income of -$1.28B for the fiscal year ended 2025-11-30. This page shows 7 annual periods of income statement, balance sheet and cash flow figures normalized from Concentrix Corp’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Business Services, NEC.
Income
| Metric | 2025-11-30 | 2024-11-30 | 2023-11-30 | 2022-11-30 | 2021-11-30 | 2020-11-30 | 2019-11-30 |
|---|---|---|---|---|---|---|---|
| Revenue | $9.83B | $9.62B | $7.11B | $6.32B | $5.59B | $4.72B | $4.71B |
| Cost of revenue | $6.39B | $6.17B | $4.54B | $4.07B | $3.62B | $3.06B | $2.96B |
| Gross profit | $3.44B | $3.45B | $2.58B | $2.26B | $1.97B | $1.66B | $1.75B |
| Operating income | -$918.18M | $596.39M | $661.33M | $640.19M | $572.40M | $308.76M | $294.33M |
| Net income | -$1.28B | $251.22M | $313.84M | $435.05M | $405.58M | $164.81M | $117.16M |
| Research & development | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Weighted-average diluted shares | shares 63.01M | shares 65.07M | shares 54.01M | shares 51.74M | shares 51.91M | shares 51.60M | shares 51.60M |
| Pretax income | -$1.18B | $299.27M | $408.23M | $605.00M | $555.70M | $267.90M | $204.42M |
| Income tax expense | $96.70M | $48.06M | $94.39M | $169.36M | $150.12M | $103.08M | $87.25M |
| Diluted EPS | $-20.36 | $3.71 | $5.70 | $8.28 | $7.70 | $3.19 | $2.27 |
| Selling, general & administrative | $2.83B | $2.85B | $1.92B | $1.62B | $1.40B | $1.35B | $1.45B |
| General & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2025-11-30 | 2024-11-30 | 2023-11-30 | 2022-11-30 | 2021-11-30 | 2020-11-30 | 2019-11-30 |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $327.35M | $240.57M | $295.34M | $145.38M | $182.04M | $152.66M | Unavailable |
| Total assets | $10.76B | $11.99B | $12.49B | $6.67B | $5.05B | $5.18B | Unavailable |
| Current assets | $3.08B | $2.84B | $2.86B | $1.75B | $1.54B | $1.42B | Unavailable |
| Total liabilities | $8.02B | $7.95B | $8.35B | $3.97B | $2.43B | $2.88B | Unavailable |
| Current liabilities | $2.20B | $2.00B | $2.07B | $1.13B | $968.21M | $1.01B | Unavailable |
| Total equity incl. NCI | $2.74B | $4.04B | $4.14B | $2.70B | $2.62B | $2.30B | $1.47B |
| Temporary (mezzanine) equity | Unavailable | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Accounts receivable | $2.00B | $1.93B | $1.89B | $1.39B | $1.21B | $1.08B | Unavailable |
| Goodwill | $3.67B | $4.99B | $5.08B | $2.90B | $1.81B | $1.84B | $1.83B |
| Long-term debt | $4.57B | $4.73B | $4.94B | $2.22B | $802.02M | $1.11B | Unavailable |
| Accounts payable | $244.77M | $209.81M | $243.56M | $161.19M | $129.36M | $140.58M | Unavailable |
Cash flow
| Metric | 2025-11-30 | 2024-11-30 | 2023-11-30 | 2022-11-30 | 2021-11-30 | 2020-11-30 | 2019-11-30 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $806.97M | $667.49M | $678.01M | $600.72M | $514.18M | $507.61M | $449.74M |
| Capital expenditures | $234.50M | $238.76M | $180.53M | $140.02M | $149.08M | $171.33M | $111.12M |
| Investing cash flow | -$250.38M | -$244.27M | -$2.11B | -$1.84B | -$78.65M | -$109.22M | -$151.01M |
| Financing cash flow | -$491.44M | -$492.53M | $1.80B | $1.24B | -$401.87M | -$335.22M | -$339.64M |
| Net change in cash | $91.52M | -$86.88M | $359.02M | -$25.55M | $26.66M | $72.84M | -$44.37M |
| Stock-based compensation | $96.39M | $96.06M | $62.11M | $47.14M | $36.18M | $15.57M | $10.35M |
| Common dividends paid | $89.62M | $83.81M | $63.50M | $53.43M | $13.08M | $0 | $0 |
| Common share repurchases | $168.71M | $136.10M | $63.96M | $120.82M | $25.10M | $0 | $0 |
| Depreciation & amortization | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Derived
| Metric | 2025-11-30 | 2024-11-30 | 2023-11-30 | 2022-11-30 | 2021-11-30 | 2020-11-30 | 2019-11-30 |
|---|---|---|---|---|---|---|---|
| Free cash flow | $572.47M | $428.73M | $497.48M | $460.70M | $365.10M | $336.28M | $338.61M |
| Gross margin | 35.0% | 35.9% | 36.2% | 35.7% | 35.3% | 35.2% | 37.1% |
| Operating margin | -9.3% | 6.2% | 9.3% | 10.1% | 10.2% | 6.5% | 6.3% |
| FCF margin | 5.8% | 4.5% | 7.0% | 7.3% | 6.5% | 7.1% | 7.2% |
| SBC / revenue | 1.0% | 1.0% | 0.9% | 0.7% | 0.6% | 0.3% | 0.2% |
| Current ratio | 1.40x | 1.42x | 1.38x | 1.55x | 1.59x | 1.41x | Unavailable |
| Revenue YoY growth | 2.2% | 35.2% | 12.5% | 13.2% | 18.4% | 0.2% | Unavailable |
| Net margin | -13.0% | 2.6% | 4.4% | 6.9% | 7.3% | 3.5% | 2.5% |
| R&D / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| CapEx / revenue | 2.4% | 2.5% | 2.5% | 2.2% | 2.7% | 3.6% | 2.4% |
| Long-term debt / equity | 1.67x | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | Unavailable | 16.1% | 23.1% | 28.0% | 27.0% | 38.5% | 42.7% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open CNXC in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-07-02View SEC filing
10-Q · Filed 2026-04-03View SEC filing
10-K · Filed 2026-01-28View SEC filing
10-Q · Filed 2025-10-03View SEC filing
10-Q · Filed 2025-07-03View SEC filing
10-Q · Filed 2025-04-04View SEC filing
Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.